Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

13.03.25 14:30 Uhr

Werte in diesem Artikel
Aktien

6,80 EUR -0,30 EUR -4,23%

For the quarter ended December 2024, Inogen (INGN) reported revenue of $80.08 million, up 5.5% over the same period last year. EPS came in at -$0.41, compared to -$1.14 in the year-ago quarter.The reported revenue represents a surprise of +0.73% over the Zacks Consensus Estimate of $79.5 million. With the consensus EPS estimate being -$0.57, the EPS surprise was +28.07%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Inogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Sales revenue: $66.31 million compared to the $60.33 million average estimate based on two analysts. The reported number represents a change of +11.6% year over year. Revenue- Rental revenue: $13.77 million compared to the $13.63 million average estimate based on two analysts. The reported number represents a change of -16.5% year over year. Gross profit- Rental revenue: $5.48 million compared to the $5.49 million average estimate based on two analysts. Gross profit- Sales revenue: $30.81 million versus the two-analyst average estimate of $26.37 million. View all Key Company Metrics for Inogen here>>>Shares of Inogen have returned -22.3% over the past month versus the Zacks S&P 500 composite's -7.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inogen, Inc (INGN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Inogen

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Inogen

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Inogen Inc

Wer­bung

Analysen zu Inogen Inc

DatumRatingAnalyst
07.08.2019Inogen HoldNeedham & Company, LLC
28.06.2019Inogen BuyNeedham & Company, LLC
08.05.2019Inogen Strong BuyNeedham & Company, LLC
27.02.2019Inogen Strong BuyNeedham & Company, LLC
20.11.2018Inogen Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
28.06.2019Inogen BuyNeedham & Company, LLC
08.05.2019Inogen Strong BuyNeedham & Company, LLC
27.02.2019Inogen Strong BuyNeedham & Company, LLC
20.11.2018Inogen Strong BuyNeedham & Company, LLC
07.11.2018Inogen BuyNeedham & Company, LLC
DatumRatingAnalyst
07.08.2019Inogen HoldNeedham & Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Inogen Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen